How has Mind Medicine (MindMed)'s stock price been impacted by COVID-19?
Mind Medicine (MindMed)'s stock was trading at $0.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organi...
Who are Mind Medicine (MindMed)'s key executives?
Mind Medicine (MindMed)'s management team includes the following people: Mr. Jamon Alexander Rahn , Co-Founder, CEO & Director Dr. Miriam Halperi...
Who are some of Mind Medicine (MindMed)'s key competitors?
Some companies that are related to Mind Medicine (MindMed) include (TNGN) (TNGN) , 3SBio (TRSBF) , 45525 (CUR.TO) (CUR) , Abattis Bioceuticals...
What is Mind Medicine (MindMed)'s stock symbol?
Mind Medicine (MindMed) trades on the OTCMKTS under the ticker symbol "MMEDF."
How do I buy shares of Mind Medicine (MindMed)?
Shares of MMEDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is Mind Medicine (MindMed)'s stock price today?
One share of MMEDF stock can currently be purchased for approximately $4.69.
How many employees does Mind Medicine (MindMed) have?
Mind Medicine (MindMed) employs 22 workers across the globe.
What is Mind Medicine (MindMed)'s official website?
The official website for Mind Medicine (MindMed) is www.mindmed.co .
Recently Viewed Tickers
Visit a quote page and your recently viewed tickers will be displayed here.
Mind Medicine (MindMed) Inc
Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M.
Is Mind Medicine (MindMed) a buy right now?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mind Medicine (MindMed) in the last twelve months. There are currently 1 buy rating for the stock.
What stocks does MarketBeat like better than Mind Medicine (MindMed)?
Wall Street analysts have given Mind Medicine (MindMed) a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mind Medicine (MindMed) wasn't one of them.
How has Mind Medicine (MindMed)'s stock price been impacted by Coronavirus?
Mind Medicine (MindMed)'s stock was trading at $0.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MMEDF stock has increased by 685.7% and is now trading at $2.75.#N#View which stocks have been most impacted by COVID-19.
What price target have analysts set for MMEDF?
1 equities research analysts have issued 1-year price targets for Mind Medicine (MindMed)'s shares. Their forecasts range from $2.00 to $2.00. On average, they anticipate Mind Medicine (MindMed)'s share price to reach $2.00 in the next twelve months.
Who are some of Mind Medicine (MindMed)'s key competitors?
Some companies that are related to Mind Medicine (MindMed) include (TNGN) (TNGN), 3SBio (TRSBF), 45525 (CUR.TO) (CUR), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS), Amplia Therapeutics (ATX), Anatara Lifesciences (ANR) and Annovis Bio (ANVS).#N#View all of MMEDF's competitors..
What is Mind Medicine (MindMed)'s stock symbol?
Mind Medicine (MindMed) trades on the OTCMKTS under the ticker symbol "MMEDF."
How do I buy shares of Mind Medicine (MindMed)?
Shares of MMEDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.#N#Compare Top Brokerages Here.
Is Mind Medicine (MindMed) a buy right now?
3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Mind Medicine (MindMed) in the last year. There are currently 3 buy ratings for the stock.
What stocks does MarketBeat like better than Mind Medicine (MindMed)?
Wall Street analysts have given Mind Medicine (MindMed) a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Mind Medicine (MindMed) wasn't one of them.
When is Mind Medicine (MindMed)'s next earnings date?
Mind Medicine (MindMed) is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.#N#View our earnings forecast for Mind Medicine (MindMed).
How were Mind Medicine (MindMed)'s earnings last quarter?
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) posted its quarterly earnings data on Thursday, August, 12th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.04) by $0.05.#N#View Mind Medicine (MindMed)'s earnings history.
What price target have analysts set for MNMD?
3 analysts have issued 1-year price objectives for Mind Medicine (MindMed)'s stock. Their forecasts range from 4.25 to 10.00. On average, they anticipate Mind Medicine (MindMed)'s stock price to reach 6.75 in the next twelve months.
Who are some of Mind Medicine (MindMed)'s key competitors?
Some companies that are related to Mind Medicine (MindMed) include 1Life Healthcare (ONEM), Adagio Therapeutics (ADGI), BTG (BTG), Integer (ITGR), Arena Pharmaceuticals (ARNA), Cortexyme (CRTX), Haemonetics (HAE), Bavarian Nordic A/S (BVNRY), Insmed (INSM), NuVasive (NUVA), AdaptHealth (AHCO), The Beauty Health (SKIN), Kymera Therapeutics (KYMR), Cronos Group (CRON) and ALX Oncology (ALXO).#N#View all of MNMD's competitors..
What is Mind Medicine (MindMed)'s stock symbol?
Mind Medicine (MindMed) trades on the NASDAQ under the ticker symbol "MNMD."
Signals & Forecast
Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Mind Medicine (MindMed) Inc.
Support, Risk & Stop-loss
Mind Medicine (MindMed) Inc. Subordinate finds support from accumulated volume at $2.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Is Mind Medicine (MindMed) Inc. Subordinate Voting Shares stock A Buy?
Mind Medicine (MindMed) Inc. Subordinate holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
